Kevin Chua, Radiation Oncologist at National Cancer Center Singapore, shared a post on X:
“Happening right now at ASCOBT26
Morning plenary session on making clinical AI a reality at the bedside – Discussion featuring clinicians, academics and industry!
After starting with a patient case presentation by Dr David Goldstein, Dr Naveen Nagar describes the challenges and opportunities for AI adoption in LMICs.
Next, Dr Daniel Truhn and Dr Arsela Prelaj showed how clinical AI in diagnostic imaging combined with agentic AI can support more effective MDT decision making in oncology by using the patient case as an example.
Finally, Dr Huren Sivaraj from Oncoshot shared real-world examples of how AI is already improving efficiency in clinical trial screening.”
